The experience and impact of living with gout: A study of men with chronic gout using a qualitative grounded theory approach

Journal of Clinical Rheumatology

Volumn 17, Issue 1, 2011, Pages 1-6

  Lindsay, Karen ^a   Gow, Peter ^a   Vanderpyl, Jane ^a   Logo, Phillip ^a   Dalbeth, Nicola ^a,b  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Gout; grounded theory; impact; qualitative

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; FUNCTIONAL STATUS; GOUT; HUMAN; MALE; PAIN; PATIENT ATTITUDE; PRIORITY JOURNAL; SHAME; SOCIAL STIGMA;

ADULT; AGED; ALLOPURINOL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATTITUDE TO HEALTH; CHRONIC DISEASE; DIET; DISEASE PROGRESSION; EXERCISE; FEMALE; GOUT; GOUT SUPPRESSANTS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUALITATIVE RESEARCH; QUALITY OF LIFE; SOCIAL SUPPORT;

EID: 78651354613     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318204a8f9     Document Type: Article

References (26)

1. Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford). 2007;46:1441-1444.
2. Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout Rheumatology (Oxford). 2009;48:582-586.
3. Hirsch JD, Lee SJ, Terkeltaub R, et al. Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol. 2008;35:2406-2414.
4. Singh JA, Strand V Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67:1310-1316.
5. Dalbeth N, Collis J, Gregory K, et al. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford, England). 2007;46:1804-1807.
6. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1301-1311.
7. Owens D, Whelan B, McCarthy G. A survey of the management of gout in primary care. Ir Med J. 2008;101:147-149.
8. Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis. 2007;66:1311-1315.
9. Harrold LR, Andrade SE, Briesacher BA, et al. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 2009;11:R46.
10. Perez-Ruiz F, Calabozo M, Fernandez-Lopez MJ, et al. Treatment of chronic gout in patients with renal function impairment an open, randomized, actively controlled study. J Clin Rheumatol. 1999;5:49-55.
11. Day RO. Adherence to urate-lowering therapy. South Med J. 2009;102:114-115.
12. Riedel AA, Nelson M, Joseph-Ridge N, et al. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31:1575-1581.
13. Sarawate CA, Brewer KK, Yang W, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006;81:925-934.
14. Sarawate CA, Patel PA, Schumacher HR, et al. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol. 2006;12:61-65.
15. O'Hare R, Muir A, Chapman S, et al. Identification of the pharmaceutical care issues of rheumatoid arthritis patients in secondary care. Pharm WorldSci. 2001;23:183-184.
16. Backman CL, Smith Ldel F, Smith S, et al. Experiences of mothers living with inflammatory arthritis. Arthritis Rheum. 2007;57:381-388.
17. Davis GC, Hiemenz ML, White TL. Barriers to managing chronic pain of older adults with arthritis. JNurs Scholarsh. 2002;34:121-126.
18. Eyckmans L, Hilderson D, Westhovens R, et al. What does it mean to grow up with juvenile idiopathic arthritis? A qualitative study on the perspectives of patients. Clin Rheumatol. DOI: 10.1007/s10067-010-1444-0 (Published online first 10th April 2010).
19. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895-900.
20. Miles MB. Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. Thousand Oaks, CA: Sage; 1994.
21. Charmaz K. Grounded theory: objectivist and constructivist methods. In: Denzin NK, LYS, editors. Handbook of Qualitative Research. 2nd ed. Thousand Oaks, CA: Sage Publications, Inc; 2000.
22. Strauss AL, Corbin J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, CA: Sage Publications, Inc; 1998.
23. Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health. 2007;10:231-237.
24. Hollis-Moffatt JE, Xu X, Dalbeth N, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum. 2009;60:3485-3492.
25. Dalbeth N, Kumar S, Stamp L, et al. Dose adjustment ofallopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol. 2006;33: 1646-1650.
26. Winnard D, Kake T, Gow P, et al. Debunking the myths to provide 21st century management of gout. N Z Med J. 2008;121:79-85.